Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data

In contrast to continuous positive airway pressure (CPAP), the use of adaptive servo-ventilation (ASV) for treatment of central sleep apnoea (CSA) was associated with increased mortality in patients with chronic systolic heart failure (CHF). In order to characterize the interplay between sleep-disordered breathing, CHF and sympathovagal balance (SVB) this study investigated the effect of nocturnal CPAP and ASV on SVB in CSA patients with or without CHF.

Source: International Journal of Cardiology - April 1, 2020 Category: Cardiology Authors: Martha Gorbachevski, Jens Spiesshoefer, Michael Arzt, Olaf Oldenburg, Sara Becker, Izabela Tuleta, Michele Emdin, Claudio Passino, Paolo Sciarrone, Matthias Boentert, Alberto Giannoni Source Type: research